📄 Cross-examination of Gary Sims (part 2) — Thursday, May 18, 1995
Address:
C:\DEPT103\CRIMINAL\1995\MAY\18\CROSS-EXAMINATION-OF-GARY-SIMS.DOC
TRIAL
▲ Day 77 of 167

Cross-examination of Gary Sims (part 2)

Witness: Gary Sims
Examiner: Barry Scheck
Called by: Prosecution • Date: Thursday, May 18, 1995 • Utterances: 354
Barry Scheck cross-examines Gary Sims, a DNA analyst from the California DOJ lab, on laboratory protocols for preventing cross-contamination. Scheck methodically walks Sims through his own lab's protocol (section 6.3) and the Amplitype user guide, extracting concessions that proper procedure requires separating suspect from victim samples, separating reference from evidence samples in time and place, and limiting batch sizes — then revealing that Sims processed 21 Bronco samples at once, exceeding the guide's recommended 15. The examination builds a foundation for the defense contamination theory without yet delivering a knockout blow.
1 (Brief pause.)
2 MR. SCHECK:

Sorry. Why don't you just--in terms of my hypothetical, why don't you just assume that you handled the swatch, swatches that were collected an hour, hour and a half before you got to the laboratory first and then the other sample second.

3 MR. SIMS:

So you did them as two separate sets? Is that what you're saying?

4 MR. SCHECK:

You did--plastic bag no. 1, you handled from the--that was the one that contained the swatches an hour, hour and a half old.

5 MR. SIMS:

Okay.

6 MR. SCHECK:

Right? Plastic bag no. 2 came from the samples that were seven hours in the plastic bag from the dirty surfaces.

7 MR. SIMS:

Okay. So as I understand this now, somebody's taking what I would call a culture tube? Is that the right size?

8 MR. SCHECK:

A test tube.

9 MR. SIMS:

Test tube. They're sticking that tube into a plastic envelope to capture the swatch into that tube?

10 MR. SCHECK:

Uh-huh. Wet swatch.

11 MR. SIMS:

A wet swatch. I would say one should change gloves between those two sets, yes.

KEY QUOTE
12 MR. SCHECK:

Let's say you didn't change gloves.

13 MR. SIMS:

Well, if you--I mean, the other thing about blood is, it's very visible, and one may look at the gloves and see whether or not there was any visible contamination that way.

14 MR. SCHECK:

You didn't change gloves. Are you saying, Mr. Sims, that that's the kind of laboratory practice that you would engage in?

15 MR. SIMS:

No.

16 MR. SCHECK:

Now, let's talk about--let's turn to--like to go actually to I think it's F, the one that's F. Yes. Now, samples that come from a victim and samples that come from a suspect, assume they're blood swatches.

17 MR. SIMS:

Okay.

18 MR. SCHECK:

You should handle those separately?

19 MR. SIMS:

Separately--

20 MR. HARMON:

Objection. It's vague. Separately from what?

21 THE COURT:

Sustained.

22 MR. SCHECK:

Should you examine those separately?

23 MR. HARMON:

Same objection, your Honor.

24 THE COURT:

Why don't you ask--why don't you clarify that, Mr. Scheck.

25 MR. SCHECK:

All right. Let's try this. Would you agree that items of evidence collected from suspects should be handled separately from evidence samples?

26 MR. SIMS:

Yes.

27 MR. SCHECK:

Because this practice guards against sample mix up and cross-transfer?

28 MR. SIMS:

Yes.

29 MR. SCHECK:

You have a protocol in your laboratory?

30 MR. SIMS:

Yes, we do.

31 MR. SCHECK:

It's a detailed protocol?

32 MR. SIMS:

Yes, it is.

33 MR. SCHECK:

Are you familiar with section 6.3 of your protocol?

34 MR. SIMS:

I don't know the protocol by number, but if you read it to me, I'll let you know or you show it to me, I'll--

35 MR. SCHECK:

All right.

36 (Brief pause.)
37 MR. SCHECK:

Section 6.3 of your protocol concerns the examination of samples.

38 MR. SIMS:

Yes, it does.

39 MR. SCHECK:

We're just talking now about looking at them and examining them.

40 MR. SIMS:

Yes.

41 MR. SCHECK:

We're not talking at this stage about cutting them.

42 MR. SIMS:

Yes.

43 MR. SCHECK:

We're not talking at this stage about packaging and handling them.

44 MR. SIMS:

Well, now wait. We have to back up. When we're talking about examining them, there may be some cutting. I'm sorry. I agreed with you too quickly on that one.

45 MR. SCHECK:

Okay. It's all right.

46 MR. SIMS:

Yes. We are talking about having the evidence out there and sampling it.

47 MR. SCHECK:

And this section of your own protocol is something you rely on?

48 MR. SIMS:

Yes, it is.

49 MR. SCHECK:

Something you think is a good idea?

50 MR. SIMS:

Yes, I do.

51 MR. SCHECK:

And in your protocol, does it not state that in general, the examiner should examine only one item of evidence at a time.

52 MR. SIMS:

Yes.

53 MR. SCHECK:

Marking the evidence with the unique identifier.

54 MR. SIMS:

Yes.

55 MR. SCHECK:

Returning it to its container before opening another item.

56 MR. SIMS:

Yes.

57 MR. SCHECK:

And in particular, items of evidence collected from suspects should be examined separately from victim samples.

58 MR. SIMS:

Yes.

59 MR. SCHECK:

And that's a practice that your protocol indicates will guard against sample mix up and cross-transfer?

60 MR. SIMS:

Yes.

61 MR. SCHECK:

And you think that's an important precaution to take against cross-contamination, don't you?

62 MR. SIMS:

Cross-contamination and sample mix up, yes.

63 MR. SCHECK:

And mix-up of samples?

64 MR. SIMS:

Yes.

65 MR. SCHECK:

So in terms of this logo which we don't intend to have--clip-art's limited and it's not supposed to look like men's room and women's room, all goes. But you agree with this principal that one should separate suspect, victim samples?

66 MR. SIMS:

Yes.

67 MR. SCHECK:

Now--

68 MR. SCHECK:

Let's turn to E.

69 MR. SCHECK:

Now, wouldn't you agree that of extraordinary importance is the need to handle reference samples, be it from a suspect or victims, separately from evidence samples?

70 MR. HARMON:

Objection. "handled" and "separately" are vague, your Honor.

71 THE COURT:

Rephrase.

72 MR. SCHECK:

Just in terms of--would you try to keep separate the taking of any blood from a reference sample in terms of the time and place from the examination, cutting or handling of an evidence sample?

73 MR. SIMS:

By that, do you mean, for example, preparing a swatch of the reference stain or the reference sample?

74 MR. SCHECK:

Yes.

75 MR. SIMS:

That sort of thing? Yes.

76 MR. SCHECK:

That is a cardinal rule, isn't it?

KEY QUOTE
77 MR. SIMS:

Well, I don't--I don't know if it's a cardinal rule, but it is an important concept, yes.

78 MR. SCHECK:

That's in your protocol?

79 MR. SIMS:

It may be. The exact wording, I'm not sure of. But again, I think it's important.

80 MR. SCHECK:

Are you familiar--did I give you the amplitype guide?

81 MR. SIMS:

Yes, I have it here.

82 MR. SCHECK:

All right. Why don't you again look at section 2.2.2, "special precautions."

83 MR. SIMS:

Okay.

84 MR. SCHECK:

Ask you to look at sentence 1.

85 MR. SIMS:

Okay.

86 MR. SCHECK:

Starting with, "it is important."

87 MR. SIMS:

Okay.

88 MR. SCHECK:

Do you rely on that section?

89 MR. HARMON:

Objection. It's vague. Rely on for what reason?

90 THE COURT:

Overruled. Obviously for the application of this process.

91 MR. SCHECK:

Let me make sure I'm pointing to the right sentence.

92 THE COURT:

2.2.2 on page 2.

93 MR. SCHECK:

Yes.

94 MR. SIMS:

Number 1? Oh, okay. (Brief pause.)

95 MR. SIMS:

I do agree and I do practice that the DNA extraction will be separated in time from the reference samples against the evidence samples, but the PCR setup of evidence samples, it says, "should be performed at a separate time from the DNA extraction PCR setup of reference samples." I--I don't--I don't follow that. Usually what I do is, I put the evidence samples first in a set that I'm going to be doing the PCR analysis on and then I get to the evidence--I'm sorry--the reference samples last along the stream so that you don't start upstream with the reference samples. Instead, they're downstream from that process. But I do extract them separately, yes. I agree with that part of that.

96 MR. SCHECK:

All right. Let's start with this. So it is--you would agree that it is important that "DNA extraction--"

97 MR. HARMON:

Objection. Calls for hearsay, your Honor. He's reading.

98 THE COURT:

Overruled.

99 MR. SCHECK:

"DNA extraction of evidence samples be performed at a separate time from DNA extraction of reference samples"?

100 MR. SIMS:

Yes.

101 MR. SCHECK:

And this precaution will help prevent potential cross-contamination between evidence samples and reference samples?

102 MR. SIMS:

I agree with that.

103 MR. SCHECK:

Now, you're familiar with the California association of crime lab directors open proficiency tests in 1988 and `89?

104 MR. SIMS:

I have some familiarity with them, yes.

105 MR. SCHECK:

And you have studied the factors that led to false positives by different DNA laboratories that participated in that open proficiency test?

106 MR. HARMON:

Objection. It's irrelevant, calls for hearsay.

107 THE COURT:

Sustained.

108 MR. SCHECK:

All right. Are you aware--have you familiar--without going into the content yet, have you familiarized yourself with the circumstances surrounding false positives obtained by the Cellmark laboratory?

109 MR. HARMON:

Objection. Irrelevant.

110 THE COURT:

Sustained.

111 MR. SCHECK:

All right. With respect to false positives arising from RFLP testing, when a laboratory is handling, at the same time, reference samples from a suspect and evidence samples, are you aware of false positives ever arising in that context?

112 MR. HARMON:

Objection. Calls for hearsay. It's irrelevant.

113 THE COURT:

Overruled.

114 MR. SIMS:

In other words, am I aware of any documented example of that?

115 MR. SCHECK:

Yeah.

116 MR. SIMS:

I--when you were that specific, I couldn't recall that. I--I am aware of sample mix-ups, but I wasn't sure of the actual what got mixed up with what.

117 MR. SCHECK:

Well, before you came in here to testify, Mr. Sims, you were watching this proceeding on television?

118 MR. SIMS:

Some of it, yes.

119 MR. SCHECK:

When Dr. Cotton was testifying, weren't you upstairs in the Prosecutor's office watching television in terms of her testimony?

120 MR. SIMS:

I actually spent very little time up there watching television.

121 MR. SCHECK:

Where did you watch it?

122 MR. SIMS:

I watched some of it in my hotel room and I watched a little bit of it when I was upstairs. But most of the time that I'm upstairs, I'm not watching the television.

123 MR. SCHECK:

Did you watch her testimony?

124 MR. SIMS:

Some of it.

125 MR. SCHECK:

Watch cross-examination?

126 MR. SIMS:

Some of it.

127 MR. SCHECK:

Talk about it with the Prosecutors?

128 MR. SIMS:

A little bit.

129 MR. SCHECK:

In your reading in terms of forensic DNA testing, have you read literature concerning false positives on the CACLD tests?

130 MR. HARMON:

Objection. It's irrelevant, calls for hearsay, 721 of the evidence code, your Honor.

131 THE COURT:

Sustained.

132 MR. SCHECK:

Were the false positives in the CACLD tests a matter of concern to people in the forensic DNA community?

133 MR. HARMON:

Objection. It's irrelevant, calls for hearsay, 721 of the evidence code, assumes facts not in evidence.

134 MR. SCHECK:

I'm only asking if it was a matter of concern.

135 MR. HARMON:

It assumes that--

136 THE COURT:

Overruled.

137 MR. HARMON:

--that he knows it.

138 THE COURT:

Overruled.

139 MR. HARMON:

I'm sorry.

140 MR. SIMS:

Yes.

141 MR. SCHECK:

You recall when those results were announced?

142 MR. SIMS:

Yes, I do, roughly the date, the time.

143 MR. SCHECK:

And you recall that you mentioned Dr. Blake?

144 MR. SIMS:

Yes.

145 MR. SCHECK:

He participated in those tests?

146 MR. SIMS:

Yes, he did.

147 MR. SCHECK:

He got a false positive in the first round too?

148 MR. SIMS:

I believe it was a false positive, although it may have been a false negative. I'm not sure, but he did have a problem on one sample I recall.

149 MR. SCHECK:

And he was using PCR?

150 MR. SIMS:

That's correct.

151 MR. SCHECK:

And Cellmark was using RFLP?

152 MR. SIMS:

Cellmark, my understanding, was using RFLP. Dr. Blake was using PCR DQ-Alpha in the--a different dot blot format than is used now.

153 MR. SCHECK:

Did you hear Dr. Cotton's testimony with respect to how the false positives arose in the CACLD tests?

154 MR. SIMS:

You know, I think I missed that part.

155 MR. SCHECK:

You did?

156 MR. SIMS:

I--I don't recall hearing all that.

157 MR. SCHECK:

In your review of the literature with respect to the CACLD open proficiency tests, did you become aware of a false positive arising when samples, evidence samples were handled--

158 MR. HARMON:

Objection. Improper foundation, 721, it's hearsay.

159 THE COURT:

Sustained.

160 MR. SCHECK:

With respect to handling reference samples the same time in the same area as evidence samples, all right?

161 MR. SIMS:

Okay.

162 MR. SCHECK:

Isn't that a particularly dangerous practice because the reference sample has a high concentration of DNA in the whole blood?

163 MR. HARMON:

Objection. It's compound, same time and area, it's vague, same time and area, particularly dangerous practices.

164 MR. SCHECK:

I think he's already conceded that.

165 THE COURT:

All right. Overruled.

166 MR. HARMON:

It's also argumentative.

167 THE COURT:

Overruled.

168 MR. SIMS:

Now, again, could you--when you describe the same--is it what, the same time and the same place? Is that what you're saying?

169 MR. SCHECK:

Yeah. You discussed before--remember you saying pouring out a reference sample and making a card in the same area--

170 MR. SIMS:

Yes.

171 MR. SCHECK:

--that one is then handling reference samples.

172 MR. SIMS:

You mean that one is then handling evidence samples?

173 MR. SCHECK:

That's right. Evidence samples.

174 MR. SIMS:

Yes. I think that would not be a good idea.

175 MR. SCHECK:

And one of the reasons it's not a good idea is that the reference sample contains a high concentration of DNA in the whole blood?

176 MR. SIMS:

That's correct.

177 MR. SCHECK:

And a very small amount of blood, talking microliter--

178 MR. SIMS:

Yes.

179 MR. SCHECK:

--that is transferred to an evidence specimen can cause a cross-contamination?

180 MR. SIMS:

That's true.

181 MR. SCHECK:

A microliter of blood contains how many nanograms high molecular weight DNA would you estimate?

182 MR. SIMS:

Yes. That would be about 20 nanograms, something like that, per microliter because it's about 20 microliter--or I'm sorry--about 20 micrograms per mil. So you're taking it down--that sounds right. About 20 nanograms per microliter whole blood.

183 MR. SCHECK:

Could be more?

184 MR. SIMS:

It could be more. Some people have more, some people have less.

185 MR. SCHECK:

And did you hear Dr. Cotton's testimony with respect to how much DNA was in the evidence lane of item 52 in her RFLP test?

186 MR. HARMON:

Objection. Calls for hearsay.

187 THE COURT:

Sustained.

188 MR. SCHECK:

All right. Are you aware of how much DNA was in the reference lane for 52 in the Cellmark RFLP test?

189 MR. HARMON:

Objection. Still calls for hearsay, no foundation, calls for speculation.

190 THE COURT:

It's also irrelevant. Sustained.

191 MR. SCHECK:

Irrelevant?

192 THE COURT:

It's already in the record, counsel.

193 MR. SCHECK:

Well--that's the point.

194 THE COURT:

If you want to pose it as a hypothetical of a particular nanogram--

195 MR. SCHECK:

Okay. Okay.

196 MR. SCHECK:

If there were cross-contam--

197 MR. SCHECK:

Thank you. It's a long day.

198 MR. SCHECK:

If there's cross-contamination of microliter particle blood to a swatch, that could cause as much as 20 nanograms, 25 nanograms high molecular weight DNA to be on a swatch?

199 MR. SIMS:

Yes.

200 MR. SCHECK:

And you can get RFLP results from as little as 25 nanograms?

201 MR. SIMS:

On a good day, yes.

202 MR. SCHECK:

Now--and of course, it would--you can get PCR results on how much DNA?

203 MR. SIMS:

In our laboratory, the limit we would test would be down in the--what we would call 300 picograms which is 0.3 nanograms.

204 MR. SCHECK:

Let's talk small here. A nanogram is a billionth of a gram?

205 MR. SIMS:

That's correct.

206 MR. SCHECK:

So what's a picogram?

207 MR. SIMS:

That's a trillionth of a gram.

208 MR. SCHECK:

Can you see it with the naked eye?

209 MR. SIMS:

You wouldn't see the DNA, no.

210 MR. SCHECK:

Could you see the amount of blood that it would take to--for--from which one could get--what did you say? How many picograms could you do?

211 MR. SIMS:

300 picograms.

212 MR. SCHECK:

300 picograms?

213 MR. SIMS:

Well, I think, make it a little clearer, from a bloodstain that's about a millimeter by a millimeter, you could get about two nanograms. So that's 2,000 picograms. So I think that gives you an idea of how small we're talking about. It's--

214 MR. SCHECK:

Well, is that something that you would suspect--

215 THE COURT:

Excuse me. Mr. Scheck, I don't think Mr. Sims was finished answering.

216 MR. SCHECK:

Oh, were you finished? I'm sorry.

217 MR. SIMS:

I guess I'm done.

218 MR. SCHECK:

Oh, you're finished?

219 MR. SIMS:

I lost the train anyway, so go ahead.

KEY QUOTE
220 MR. SCHECK:

Well, let's get back on the train. The--the size of--you said 300 picograms?

221 MR. SIMS:

Yes.

222 MR. SCHECK:

The size of a particle of blood that could create--from which you could extract 300 picograms of DNA, would that be visible to the naked eye?

223 MR. SIMS:

I think it would be visible, but it would be a speck. I mean, it's--it's--it's very small.

224 MR. SCHECK:

Now, and the amount of speck of blood that would give you two nanograms, it's pretty small too?

225 MR. SIMS:

Well, now, again, that's about a millimeter by a millimeter, and that's pretty small, but it's very--it's visible, very visible.

226 MR. SCHECK:

Now--

227 MR. SCHECK:

Let's see. I guess it's--let's turn to G.

228 MR. SCHECK:

Another precaution that one takes to prevent cross-contamination is not to do PCR processing on multiple samples at the same time?

229 MR. HARMON:

Objection. PCR processing is vague, your Honor.

230 THE COURT:

Sustained.

231 MR. SCHECK:

All right. In the PCR--let's talk about the PCR process a little bit.

232 MR. SIMS:

Okay.

233 MR. SCHECK:

One stage, you would literally cut the sample, correct?

234 MR. SIMS:

Yes.

235 MR. SCHECK:

What's the next stage? Would you call that part of the extraction process?

236 MR. SIMS:

No. That would be part of the sampling.

237 MR. SCHECK:

Sampling process. What's the next process?

238 MR. SIMS:

The next process, once you've got it in the tube, is to go through the actual extraction of the DNA.

239 MR. SCHECK:

All right. And you do that how?

240 MR. SIMS:

Well, in our laboratory, we do that by a procedure that involves placing the--or adding to that swatch, that stain a solution that has a soap, a detergent actually in it and an enzyme that chews up the protein, and that--that releases the DNA, and then that excess protein is removed by organic reagents, and then we do a purification step through a ultracentrifugation through a membrane.

241 MR. SCHECK:

Just visualizing it then, you take a piece of that extract, you put it in one of these little microfuge tubes?

242 MR. SIMS:

You take a piece of that swatch.

243 MR. SCHECK:

Swatch.

244 MR. SIMS:

Yes. And you put that--

245 MR. SCHECK:

Put it in one of the microfuge tubes.

246 MR. SIMS:

That's the first--

247 MR. SCHECK:

And you add all the things you were just talking about in that tube?

248 MR. SIMS:

That's correct.

249 MR. SCHECK:

All right. So you create a whole series of test tubes with these swatches?

250 MR. SIMS:

That's correct.

251 MR. SCHECK:

And some of these tubes are the ones that you were talking about before that you were calling reagent blanks?

252 MR. SIMS:

Yes. You would include reagent blanks in there.

253 MR. SCHECK:

And that would be just the tube that had just the ingredients, but no swatches?

254 MR. SIMS:

That's correct.

255 MR. SCHECK:

And when you're talking about some of those substrate controls, those would be those little tubes, but they would be the--the substrate control swatches, not the evidence specimen swatches?

256 MR. SIMS:

That's correct. They would be in there too.

257 MR. SCHECK:

All right. And you would also--you mentioned something, what you called a quality control, correct?

258 MR. SIMS:

Yes. In our laboratory, we run that.

259 MR. SCHECK:

And that's another swatch?

260 MR. SIMS:

Yes.

261 MR. SCHECK:

And you cut that swatch up and you put it in another one of those little tubes?

262 MR. SIMS:

Yes.

263 MR. SCHECK:

And then after you do what you call the extraction process, putting the swatches in the tubes and adding the ingredients, what's the next stage?

264 MR. SIMS:

Well, then after you've got that process, you end up with a solution that has just the DNA. And so then the next stage would be the evaluation of the DNA as far as quality and quantity.

265 MR. SCHECK:

That's called the slot blot?

266 MR. SIMS:

Yes. For the quantity, that's the slot blot.

267 MR. SCHECK:

All right. Quantity is that--what we call a swat blot analysis?

268 MR. SIMS:

Slot bot.

269 MR. SCHECK:

Slot blot. Did I say swat?

270 MR. SIMS:

Yes.

271 MR. SCHECK:

Slot blot analysis. You do that for all the tubes?

272 MR. SIMS:

If--if you go that route. Sometimes we use a yield gel for our quantitation.

273 MR. SCHECK:

All right. Or sometimes we've have had a discussion of something called a yield gel, right?

274 MR. SIMS:

Yes.

275 MR. SCHECK:

And that's a method by which you get an assessment of the total amount of DNA in the sample?

276 MR. SIMS:

That's correct. And--and also the quality of the DNA, whether it's degraded or not.

277 MR. SCHECK:

All right. And just so we understand what a yield gel, yield gel tells you the total amount of DNA, but it doesn't tell you whether that DNA is bacterial or human?

278 MR. SIMS:

That's correct, unless you do another procedure where you blot that gel and test it.

279 MR. SCHECK:

All right. And another procedure one can perform after the yield gel is a--what you call a southern transfer?

280 MR. SIMS:

That's correct.

281 MR. SCHECK:

And by--that's literally one of those like the RFLP gels or those little agarose--it's a little agarose gel?

282 MR. SIMS:

Yes.

283 MR. SCHECK:

And you get little bands just like we saw in the RFLP?

284 MR. SIMS:

Yes.

285 MR. SCHECK:

And those little bands, depending on how intense they are, give you some understanding of how much human DNA as opposed to bacterial DNA you have?

286 MR. SIMS:

Yes.

287 MR. SCHECK:

All right. Now, if you're doing a slot blot and you're doing 20--and you try to--withdrawn. Each stage of this procedure, whatever you're doing, you're going to do to all those different tubes?

288 MR. SIMS:

Yes.

289 MR. SCHECK:

After you do the slot blot or the yield gel or the southern transfer to that stage, what's the next stage?

290 MR. SIMS:

Well, then you would move into the typing stage, and that would be, for example, the RFLP setup, which is the restriction, or if you did PCR, that would be the amplification of the DNA.

291 MR. SCHECK:

All right. And if it were PCR, the amplification of DNA, you take those test tubes and you stick it into that thermocycler machine?

292 MR. SIMS:

Thermocycler, yes.

293 MR. SCHECK:

And that's what amplifies up--what they call the molecular Xeroxing of the DNA?

294 MR. SIMS:

That's correct.

295 MR. SCHECK:

All right. And if you were--and if you were doing "x" number of tubes to the extraction, the slot blot--then the next thing when you did the amplification, you would take it and do it with the same number of tubes, right?

296 MR. SIMS:

Yes. I mean, assuming you're going to do that with all the tubes, right. I mean, in other words, you're treating them as a group, yes.

297 MR. SCHECK:

And when you amplify them up, sometimes that's referred to sometimes as amplification run?

298 MR. SIMS:

Yes.

299 MR. SCHECK:

Now, in terms of this process, is it a good precaution to limit the quantity of samples you do in a single run to a manageable number?

300 MR. HARMON:

Objection, vague, "good precaution."

301 THE COURT:

Sustained.

302 MR. SCHECK:

All right. How many of these samples did you do at one time, the most, in this case?

303 MR. SIMS:

I have that information if I could have one second to look it up.

304 THE COURT:

And, Mr. Scheck, we'll be taking a break at 2:30.

305 MR. SCHECK:

Thank you.

306 (Brief pause.)
307 MR. SIMS:

The--the greatest number of samples that I analyzed at one time--and this would include the stains and the substrate controls plus a QC sample and an extraction blank--these were all from the Bronco, and I believe the number is 21.

KEY QUOTE
308 MR. SCHECK:

When was that?

309 MR. SIMS:

That--I can tell you I think if you look on page 34 of my notes. Yes. That was on September 21st, 1994.

310 MR. SCHECK:

What page is that?

311 MR. SIMS:

Page 34.

312 (Brief pause.)
313 MR. SCHECK:

And you're familiar with the amplitype user guide recommendation in terms of samples?

314 MR. SIMS:

Yes. I don't know the exact number in there, but I do think they mention a number.

315 MR. SCHECK:

15?

316 MR. SIMS:

15 sounds close to the right--but you have to recall that when you do this kind of test, you're really limited to the amplification of about 16 samples. Actually not the amplification, but the typing, you're limited to about 16 at a time. So that might be the number that they're discussing, because you would have to include a positive and negative control.

317 MR. SCHECK:

Well, including those.

318 MR. SIMS:

Well, yes. I--15 sounds funny to me, but it might be correct.

319 MR. HARMON:

Can we get a page number, section number?

320 MR. SCHECK:

Yeah. I'll get it.

321 THE COURT:

Mr. Sims, can you tell us, what page?

322 MR. SCHECK:

Page 4, no. 14.

323 MR. SIMS:

Is that--oh, okay. "limit the--" should I--

324 THE COURT:

Hold on.

325 MR. SCHECK:

Yeah. Read it to yourself. See if you--

326 THE COURT:

See if that refreshes your recollection.

327 MR. SCHECK:

Does that refresh your recollection?

328 MR. SIMS:

Yes, it does.

329 MR. SCHECK:

All right. The number's 15?

330 MR. SIMS:

Yes. It says approximately 15.

331 MR. SCHECK:

Now, would you agree that when performing all the operations that we talked about in terms of processing samples, it's important not to rush?

332 MR. SIMS:

I agree with that.

333 MR. SCHECK:

These are delicate procedures.

334 MR. SIMS:

Yes.

335 MR. SCHECK:

That the opening of a tube, popping of the tube and the creation of an aerosol has been known to cause cross-contamination in this process?

336 MR. HARMON:

Objection. It's argumentative, no foundation.

337 THE COURT:

Sustained.

338 MR. SCHECK:

Do you know if the popping open of the tube can cause an aerosol which creates cross-contamination in this process?

339 MR. HARMON:

Objection. "popping" is vague.

340 THE COURT:

Overruled.

341 MR. SIMS:

This would be a tube of DNA?

342 MR. SCHECK:

Yeah.

343 MR. SIMS:

Yes, I'm aware of that, and that's why we always spin our tubes down, so that won't create that aerosol problem. So we always spin a tube down before we pop it open.

344 MR. SCHECK:

You have to be careful of exactly how you touch the tops of these tubes?

345 MR. SIMS:

Well, I am--I am careful about that, yes.

346 MR. SCHECK:

One has to be. An analyst has to be.

347 MR. SIMS:

I think it's a good idea to be, yes.

348 MR. SCHECK:

Because just the touching of the top of these tubes and then the touching of the next one can cause that kind of--can cause cross-contamination?

349 MR. SIMS:

Well, not so much from the outside of the tube. I mean, it's not that there's a problem with it on the outside. As long as you spin that down, that's the main thing, that you don't have any liquid up near the top of the tube. I think that's what you mean.

350 MR. SCHECK:

Now--

351 MR. SCHECK:

Let's go to H.

352 MR. SIMS:

Okay.

353 MR. SCHECK:

Your Honor, actually, looking at h and looking at the clock, before I go into H, this might be a good time to take a break.

354 THE COURT:

Okay. Ladies and gentlemen, we are going to take our break at this point. Please remember all my admonitions to you; don't discuss the case amongst yourselves, don't form any opinions about the case, don't conduct any deliberations until the matter has been submitted to you, do not allow anybody to communicate with you. Mr. Sims, you can step down, and we'll take a 15-minute recess.

Temperature

tense

Key Quotes (5)

Gary Sims
I would say one should change gloves between those two sets, yes.
Scheck immediately follows by asking 'You didn't change gloves' and getting Sims to confirm that not doing so would be bad practice — laying groundwork for attacking LAPD collection procedures.
Barry Scheck
That is a cardinal rule, isn't it?
Scheck's attempt to elevate the separation of reference and evidence samples to a 'cardinal rule' — Sims resists the framing, calling it 'an important concept, yes,' which is a small but telling defensive move.
Gary Sims
On a good day, yes.
Sims' wry answer when asked whether RFLP results can be obtained from as little as 25 nanograms — implicitly acknowledging that cross-contamination of even a speck of blood could produce a false positive result.
Gary Sims
The greatest number of samples that I analyzed at one time...were all from the Bronco, and I believe the number is 21.
Scheck has just established the Amplitype guide recommends approximately 15 samples — Sims' admission that he ran 21 at once undercuts his adherence to recommended protocols.
Gary Sims
I lost the train anyway, so go ahead.
Rare moment of candor from the witness after being interrupted mid-answer by Scheck; humanizes Sims and lightens an otherwise dense technical proceeding.

Evidence (6)

Informal
CALJDOJ lab protocol section 6.3 — examination of samples, requiring one item at a time and separation of suspect from victim samples
discussed, used to bind Sims to his own lab's standards
Informal
Amplitype PM user guide, section 2.2.2 'Special Precautions' — requiring DNA extraction of evidence samples at a separate time from reference samples
discussed, partially agreed to by Sims with noted deviation in PCR setup stage
Informal
Amplitype PM user guide, page 4 no. 14 — recommendation to limit samples to approximately 15 per run
discussed, used to impeach Sims' 21-sample Bronco run
Informal
Gary Sims' case notes, page 34, September 21, 1994 — documenting the 21-sample Bronco analysis run
referenced by Sims to confirm date and sample count
Item 52
Cellmark RFLP test item, referenced for DNA quantity in evidence and reference lanes
discussed but objections sustained; Ito noted it was already in the record
Informal
CACLD (California Association of Crime Lab Directors) open proficiency tests, 1988 and 1989, involving false positives at Cellmark (RFLP) and by Dr. Blake (PCR DQ-Alpha)
discussed; hearsay and relevance objections repeatedly sustained, limiting Scheck's ability to develop the topic fully

Notable Exchanges (4)

Barry ScheckGary Sims
Scheck walks Sims through his own lab protocol section 6.3 line by line — examine one item at a time, mark it, return it before opening another, keep suspect and victim samples separate — and gets full agreement on each point before connecting it to what was actually done.
strategic
Barry ScheckGary Sims
Scheck reveals that Sims processed 21 Bronco samples in a single run on September 21, 1994, after having established the Amplitype guide recommends approximately 15. Sims offers a technical justification (typing limit of 16) but the damage to his protocol adherence is done.
revealing
Barry ScheckGary Sims
Scheck and Sims engage in a detailed back-and-forth on the PCR process — sampling, extraction, slot blot/yield gel, amplification — with Sims as a genuinely cooperative expert witness explaining his own methodology. Scheck uses this to establish the technical foundation for contamination risk at each step.
procedural
Barry ScheckRockne HarmonLance A. Ito
Harmon repeatedly objects on hearsay and relevance grounds to block questions about the CACLD proficiency tests and Cellmark's false positives. Ito sustains most of these, frustrating Scheck's effort to introduce industry-wide contamination history as context.
heated

Light Moments (3)

Barry Scheck
Scheck repeatedly calls the 'slot blot' a 'swat blot.' Sims corrects him: 'Slot blot.' Scheck: 'Did I say swat?'
Gary Sims
After Ito interrupts to note Sims wasn't finished answering, Sims says 'I guess I'm done' — then: 'I lost the train anyway, so go ahead.'
Barry Scheck
After Ito suggests Scheck pose a hypothetical about nanogram quantities, Scheck says 'Thank you. It's a long day.' before collecting himself.

Credibility Attacks (2)

⚔ Gary Sims
protocol violation via witness's own standards
Scheck used Sims' own lab protocol (section 6.3) and the Amplitype guide to establish best practices, then showed that Sims processed 21 Bronco samples at once — exceeding the guide's recommended ~15 — undermining his claim of rigorous protocol adherence.
⚔ Gary Sims
prior inconsistent practice
Scheck established that changing gloves between handling different sample sets is required, that handling reference and evidence samples at the same time and place is 'not a good idea,' and that Sims did not always follow these separations — allowing the jury to question whether his handling of evidence in this case was similarly careless.

Witness Demeanor

Cooperative and technically precise, willing to correct himself ('I agreed with you too quickly on that one')
Occasionally loses track mid-answer due to Scheck's interruptions
Resists loaded framing ('cardinal rule') while conceding substance
Shows mild dry wit ('On a good day, yes')

Objections

19 objections (12 sustained, 7 overruled)
Proceeding 6117 • 354 utterances • Prosecution witness
Criminal Trial
Department 103
⚖️ Start
📂 MAY 18, 1995 📄 Cross-examination of Gary Sims
MAY 18, 1995 KRT DvH TD